Patients can start and stay on Humalog U-200 KwikPen as their insulin needs increase*
*Option for patients who require >20 units of mealtime insulin/day.
Bioequivalence – with half the volume
Humalog U-200 is bioequivalent* to Humalog U-100; therefore you should expect similar efficacy and safety as Humalog U-1001. Humalog U-200 KwikPen delivers the same dose of insulin in half the liquid volume.1
Humalog U-200 was bioequivalent* to Humalog U-100 after subcutaneous administration of a single 20-unit dose in healthy subjects. Time to maximum concentration was also similar between formulations.
Select Important Safety Information
Instruct patients to always check the insulin label before each injection to avoid medication errors. Do NOT transfer Humalog U-200 from the Humalog KwikPen to a syringe as overdose and severe hypoglycemia can occur.